Mike Vallie, MBA
Mike Vallie joined ICR Westwicke in 2015, and has over a decade of experience in the healthcare industry across Investor Relations, Capital Markets Advisory, and Strategic Finance. He is exclusively focused on advising both public and pre-IPO companies in the MedTech & Diagnostics sector, with an emphasis on high-growth, early-stage stories.
Biography
Mike has advised MedTech companies across a variety of subsectors, including: neurostimulation, robotics, mental health, oncology, diabetes, sleep apnea, cardiovascular implants, pain management, spine and orthopedics, ophthalmology, aesthetics, animal health, respiratory, and diagnostic testing.
In addition to public company Investor Relations, Mike has worked directly with management teams to support and execute a number of private company transactions, including: equity financings, debt financings, IPOs, and mergers.
Prior to joining ICR Westwicke, he worked within the Healthcare Corporate Financial Strategy Consulting group at AARP, where he managed the financial planning and analysis process for a portfolio of products, developed project valuation models, performed financial due diligence, maintained risk management dashboards, and provided management consulting services throughout the organization’s Healthcare Products and Services division. He also worked alongside industry leading healthcare firms to develop, monetize and optimize co-branded insurance and financial products. Before joining AARP, Mike spent two years at JHS, a medical supplies retailer, where he oversaw the company’s marketing strategy and pricing models, conducted competitive and industry research, and helped launch new product categories.
Mike received his MBA in Finance from The Robert H. Smith School of Business at the University of Maryland, and his BS from Costello College of Business at George Mason University.
He lives in Bethesda, Maryland with his wife and two children.